Adage Capital Partners
UROV

Adage Capital Partners’s Urovant Sciences Ltd. UROV Stock Holding History

Adage Capital Partners’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-917,094
Closed -$8.46M – 821
2020
Q1 		$8.46M Sell
917,094
-32,906
-3% -$396K 0.03% 498
2019
Q4 		$14.7M Sell
950,000
-25,000
-3% -$271K 0.04% 462
2019
Q3 		$9.23M Sell
975,000
-25,000
-3% -$217K 0.02% 531
2019
Q2 		$7.91M Sell
1,000,000
-385,000
-28% -$3.16M 0.02% 557
2019
Q1 		$13.9M Hold
1,385,000
– – 0.03% 467
2018
Q4 		$9.13M Buy
1,385,000
+170,000
+14% +$1.55M 0.03% 526
2018
Q3 		$14.6M Buy
+1,215,000
New +$14.4M 0.03% 481

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Adage Capital Partners's UROV Position: Q2 2020 in Review

Adage Capital Partners sold out of Urovant Sciences Ltd. (UROV) in Q2 2020, closing a stake of 917,094 shares — an estimated $8.46M sold.

Adage Capital Partners first reported a position in UROV in Q3 2018 and held it in 7 quarters. The position peaked at $14.7M in Q4 2019. 25 funds tracked by Wall St. Rank hold UROV as of Q2 2020.

  • Adage Capital Partners reported no remaining Urovant Sciences Ltd. position as of Q2 2020 after selling out during the quarter.
  • Adage Capital Partners sold 917,094 Urovant Sciences Ltd. shares in Q2 2020, an estimated $8.46M.
  • Adage Capital Partners first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 7 quarters.
  • Adage Capital Partners's Urovant Sciences Ltd. position peaked at $14.7M in Q4 2019.
  • 25 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q2 2020.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.